MARKET

RADX

RADX

Radiopharm Theranostics Ltd
NASDAQ
4.250
0.000
0.00%
After Hours: 4.119 -0.131 -3.08% 19:58 03/27 EDT
OPEN
4.200
PREV CLOSE
4.250
HIGH
4.390
LOW
4.100
VOLUME
84.00K
TURNOVER
--
52 WEEK HIGH
16.25
52 WEEK LOW
3.496
MARKET CAP
50.21M
P/E (TTM)
-1.3843
1D
5D
1M
3M
1Y
5Y
1D
Biotech Alert: Searches spiking for these stocks today
TipRanks · 1d ago
Radiopharm Theranostics Doses First Patient in Phase 1 RAD 402 Prostate Cancer Trial
TipRanks · 1d ago
Radiopharm Theranostics Says First Patient Dosed In First-In-Human Phase 1 Clinical Trial Of RAD 402, Monoclonal Antibody Targeting KLK3 Radiolabelled With Terbium 161 Being Evaluated In Advanced Prostate Cancer
Benzinga · 1d ago
Radiopharm Theranostics doses first patient in Phase 1 RAD 402 trial for advanced prostate cancer; data from first two dose levels expected in 2H 2026
Reuters · 1d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 1d ago
Buy Rating on RADX Driven by Promising RAD 101 Phase 2b Imaging Data and Clear 2026 Clinical Milestones
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: Radiopharm Theranostics Limited Sponsored ADR (RADX), Alnylam Pharma (ALNY) and Fractyl Health, Inc. (GUTS)
TipRanks · 3d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 3d ago
More
About RADX
Radiopharm Theranostics Limited is an Australia-based clinical-stage radiotherapeutics company developing a platform of radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. The Company has a pipeline of highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase II and three Phase I trials in a variety of solid tumor cancers including lung, breast, and brain. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, and PTPu. Nano-mAbs is a novel radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilizes the early steps of fatty acid oxidation.

Webull offers Radiopharm Theranostics Ltd stock information, including NASDAQ: RADX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RADX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RADX stock methods without spending real money on the virtual paper trading platform.